These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

109 related articles for article (PubMed ID: 746051)

  • 1. Tolerance to delta9-tetrahydrocannabinol in adapted and nonadapted rabbits.
    Martin P; Consroe P
    Pharmacol Biochem Behav; 1978 Dec; 9(6):753-8. PubMed ID: 746051
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Delta-9-tetrahydrocannabinol, EEG and behavior:the importance of adaptation to the testing milieu.
    Constoe PF; Jones BC; Chin L
    Pharmacol Biochem Behav; 1975; 3(2):173-7. PubMed ID: 1144477
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The interaction of delta9-tetrahydrocannabinol with cholinomimetic drugs in an agonist-antagonist paradigm.
    Jones BC; Consroe PF; Laird HE
    Eur J Pharmacol; 1976 Aug; 38(2):253-9. PubMed ID: 954840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. EEG and behavioral effects of delta9-tetrahydrocannabinol in combination with stimulant drugs in rabbits.
    Consroe P; Jones B; Laird H
    Psychopharmacology (Berl); 1976 Oct; 50(1):47-52. PubMed ID: 827761
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Tolerance to the cardiovascular effects of delta9-tetrahydrocannabinol in the rat.
    Adams MD; Chait LD; Earnhardt JT
    Br J Pharmacol; 1976 Jan; 56(1):43-8. PubMed ID: 1252665
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interactions of delta9-tetrahydrocannabinol with other pharmacological agents.
    Consroe P; Jones B; Laird H
    Ann N Y Acad Sci; 1976; 281():198-211. PubMed ID: 798523
    [No Abstract]   [Full Text] [Related]  

  • 7. A behavioural comparison of acute and chronic Delta9-tetrahydrocannabinol and cannabidiol in C57BL/6JArc mice.
    Long LE; Chesworth R; Huang XF; McGregor IS; Arnold JC; Karl T
    Int J Neuropsychopharmacol; 2010 Aug; 13(7):861-76. PubMed ID: 19785914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversal of cannabinoids (delta9-THC) by the benzoflavone moiety from methanol extract of Passiflora incarnata Linneaus in mice: a possible therapy for cannabinoid addiction.
    Dhawan K; Kumar S; Sharma A
    J Pharm Pharmacol; 2002 Jun; 54(6):875-81. PubMed ID: 12079005
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delta9-tetrahydrocannabinol methamphetamine interaction in the rabbit.
    Consroe PF; Jones BC; Akins F
    Neuropharmacology; 1975; 14(5-6):377-83. PubMed ID: 1171388
    [No Abstract]   [Full Text] [Related]  

  • 10. Tolerance to the effect of delta9-tetrahydrocannabinol in mice on intestinal motility, temperature and locomotor activity.
    Anderson PF; Jackson DM; Chesher GB; Malor R
    Psychopharmacologia; 1975 Jul; 43(1):31-6. PubMed ID: 1161992
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behavioral effects of THC as a function of environment and prior drug experience.
    Martin P; Hodge W; Royal M; Jones B
    Pharmacol Biochem Behav; 1987 Jan; 26(1):141-4. PubMed ID: 3031696
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cross-tolerance between delta9-tetrahydrocannabinol and ethanol: the role of drug disposition.
    Siemens AJ; Doyle OL
    Pharmacol Biochem Behav; 1979 Jan; 10(1):49-55. PubMed ID: 441094
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mouse-killing and motor activity: effects of chronic delta9-tetrahydrocannabinol and pilocarpine.
    Miczek KA
    Psychopharmacology (Berl); 1976 May; 47(1):59-64. PubMed ID: 986662
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacologic interaction between cannabinol and delta9-tetrahydrocannabinol.
    Takahashi RN; Karniol IG
    Psychopharmacologia; 1975; 41(3):277-84. PubMed ID: 168604
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Relationship between body temperature and brain monoamines during the development of tolerance to delat9-tetrahydrocannabinol in the rat.
    Taylor DA; Fennessy MR
    Psychopharmacology (Berl); 1978 Apr; 56(3):279-85. PubMed ID: 418435
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Persistent effects of chronic Δ9-THC exposure on motor impulsivity in rats.
    Irimia C; Polis IY; Stouffer D; Parsons LH
    Psychopharmacology (Berl); 2015 Aug; 232(16):3033-43. PubMed ID: 25925779
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Marihuana-like activity of new synthetic tetrahydrocannabinols.
    Martin BR; Dewey WL; Harris LS; Beckner J
    Pharmacol Biochem Behav; 1975; 3(5):849-53. PubMed ID: 1208625
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of delta9-tetrahydrocannabinol with d-amphetamine, cocaine, and nicotine in rats.
    Pryor GT; Larsen FF; Husain S; Braude MC
    Pharmacol Biochem Behav; 1978 Mar; 8(3):295-318. PubMed ID: 652837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Delta 9-tetrahydrocannabinol and the sleep-wakefulness cycle in rabbits.
    Fujimori M; Himwich HE
    Physiol Behav; 1973 Sep; 11(3):291-5. PubMed ID: 4355439
    [No Abstract]   [Full Text] [Related]  

  • 20. Tolerance and dependence to Δ9-tetrahydrocannabinol in rhesus monkeys: Activity assessments.
    Wilkerson JL; Schulze DR; McMahon LR
    PLoS One; 2019; 14(3):e0209947. PubMed ID: 30861005
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.